Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Nelson

Orthopaedic Surgery Bridgeton, MO Medical Doctor

NPI 1114174265 CMS profile 141503

12349 De Paul Dr Ste 100, Bridgeton, MO 63044

Open in the dashboard

General payments

$51,712

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gregory Nelson of Bridgeton, MO is reported in the CMS Open Payments database as having received $51,712 across 133 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,041 43
2024 General $270 5
2023 General $17,521 47
2022 General $1,551 25
2021 General $25 1
2020 General $870 3
2019 General $3,433 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Nelson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Gregory Nelson were reported at $28,041. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Gregory Nelson Orthopaedic Surgery median Middle half National median
2019 $3,433 $644 $140–$2,844 $163
2020 $870 $312 $75–$1,860 $114
2021 $25 $520 $117–$2,495 $132
2022 $1,551 $598 $128–$2,731 $149
2023 $17,521 $461 $128–$2,264 $160
2024 $270 $497 $134–$2,475 $164
2025 $28,041 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $39,953 67 payments
  2. FX Shoulder USA, Inc $4,000 1 payment
  3. Wright Medical Technology, Inc. $3,284 8 payments
  4. Smith+Nephew, Inc. $2,109 7 payments
  5. Stryker Corporation $1,218 37 payments
  6. Elite Orthopedics, LLC $901 3 payments
  7. Heraeus Medical, LLC. $57 1 payment
  8. Bioventus LLC $44 2 payments
  9. Solventum Corporation $30 1 payment
  10. Ethicon US, LLC $25 1 payment
  11. Other $91 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $39,696 20 payments
  2. Travel and Lodging $8,004 35 payments
  3. Food and Beverage $3,104 76 payments
  4. Education $907 2 payments
Products named General payments · program years 2019–2025
  1. PRO-DENSE $3,269 7 payments
  2. REAL INTELLIGENCE $1,684 6 payments
  3. JOURNEY II Recon Knees $1,569 5 payments
  4. JOURNEY II Recon Knees $1,569 5 payments
  5. REDAPT $1,569 5 payments
  6. Oxford $877 5 payments
  7. VARIAX $378 18 payments
  8. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $339 6 payments
  9. GAMMA $195 10 payments
  10. REUNION $150 1 payment
  11. Other $1,096 31 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

622

Median for Orthopedic Surgery: 203

Drug cost

$7,025

Median for Orthopedic Surgery: $1,433

Branded share of claims

26.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 134 $2,937
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 119 $1,416
Oxycodone Hcl Generic 165 $1,102
Diclofenac Sodium Generic 35 $398
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 13 $290
Omeprazole Generic 37 $266
Acetaminophen-Codeine Acetaminophen With Codeine Brand 31 $250
Meloxicam Generic 24 $127
Tramadol Hcl Generic 24 $120
Cefadroxil Generic 17 $97

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 81 billing codes

Paid by Medicare

$72,506

Medicare's payments for the services billed

Medicare patients

154

Average age 72

Services billed

543

103 women, 51 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Depression 29%
Chronic kidney disease 28%
Ischemic heart disease 24%
Osteoporosis 21%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record